APA (7th ed.) Citation

J, I., N, S., S, K., H, K., Y, S., M, S., . . . SI, T. (2025). Establishment of a high-risk pediatric AML-derived cell line YCU-AML2 with genetic and metabolic vulnerabilities. International journal of hematology, 121(5), 694. https://doi.org/10.1007/s12185-025-03929-x

Chicago Style (17th ed.) Citation

J, Ikeda, et al. "Establishment of a High-risk Pediatric AML-derived Cell Line YCU-AML2 with Genetic and Metabolic Vulnerabilities." International Journal of Hematology 121, no. 5 (2025): 694. https://doi.org/10.1007/s12185-025-03929-x.

MLA (9th ed.) Citation

J, Ikeda, et al. "Establishment of a High-risk Pediatric AML-derived Cell Line YCU-AML2 with Genetic and Metabolic Vulnerabilities." International Journal of Hematology, vol. 121, no. 5, 2025, p. 694, https://doi.org/10.1007/s12185-025-03929-x.